NanoViricides Inc (NNVC) Stock Analysis

NanoViricides Inc (NNVC) is a publicly traded company in the HEALTHCARE sector. It trades at $1.59, carries a market capitalization of $38.27M. This page summarizes the public market data, fundamentals, and frequently asked questions for NNVC, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $1.59
• Market Cap: $38.27M
• EPS: $-0.44
• 52-Week High: $2.23
• 52-Week Low: $0.85

Market Sentiment

NanoViricides Inc currently has a Neutral sentiment score of 0.09.

About NanoViricides Inc

NanoViricides Inc. (NNVC) is an innovative nanobiopharmaceutical firm headquartered in Shelton, Connecticut, dedicated to the research and development of cutting-edge antiviral therapies. Leveraging its proprietary nanomedicine platform, the company creates targeted treatments that address various viral infections and significant unmet medical needs within the healthcare sector. With a robust clinical and preclinical pipeline, NanoViricides is well-positioned for substantial growth in the evo...

GNG Research Analysis

GNG Research scores NanoViricides Inc (NNVC) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NNVC.

Frequently Asked Questions

Does NNVC pay dividends?

NanoViricides Inc (NNVC) does not currently pay a regular dividend.

What is NNVC's market cap?

NanoViricides Inc (NNVC) has a market capitalization of $38.27M with a current stock price of $1.59.